Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Connective Tissue

Explore clinical trials studying Neoplasms, Connective Tissue. Study availability and eligibility vary by location and protocol.

1,268 public trials 269 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Connective Tissue trial results

Completed

A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients with Advanced GIST

NCT04530981

Conditions
Digestive System Diseases, Digestive System Neoplasms, GIST - Gastrointestinal Stromal Tumor, +7 more
Locations
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Oregon Health & Science University Portland, Oregon, United States
View Trial Details
Completed

Biospecimen Analysis in Determining Effects of Chemotherapy on Fertility in Osteosarcoma Survivors

NCT03206450

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +4 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
View all 99 locations
View Trial Details
Completed

Nilotinib Roll-over Protocol for Patients in Novartis-sponsored Nilotinib Study and Benefiting From Nilotinib Treatment

NCT01863745

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Kashiwa, Chiba, Japan
  • Novartis Investigative Site Gifu, Japan
  • Novartis Investigative Site Sapporo, Hokkaido, Japan
View Trial Details
Completed

Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas

NCT03277924

Conditions
Bone Diseases, Bone Neoplasms, Bone Sarcoma, +27 more
Locations
  • Istituto Ortopedico Rizzoli Bologna, Italy
  • Candiolo Cancer Institute - FPO, IRCCS Candiolo, Italy
  • Istituto Nazionale dei Tumori Milan, Italy
  • Hospital Universitario Fundación Jiménez Díaz Madrid, Spain
View all 13 locations
View Trial Details
Completed

A Study to Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GIST

NCT01294202

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +11 more
Locations
  • Arizona Cancer Center at UMC North Tucson, Arizona, United States
  • Robert H. Lurie Cancer Center of Northwestern University Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Apatinib With Ifosfamide Plus Etoposide for Relapsed or Refractory Osteosarcoma (OAIE)

NCT05277480

Conditions
Drug, Effect of Drug, Neoplasms, +7 more
Locations
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University Nanjing, Jiangsu, China
  • Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
View Trial Details
Completed

A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma

NCT04154189

Conditions
Disease Attributes, Neoplasms, Neoplasms by Histologic Type, +8 more
Locations
  • Children's of Alabama Birmingham, Alabama, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Benioff Children's Hospitals San Francisco, California, United States
View all 84 locations
View Trial Details

Related conditions